type is made of both hepatocellular carcinoma Although possible, HCC does not commonly and cholangiocarcinoma. This is called a spread to nearby lymph nodes. mixed-type tumor. More information on gallbladder and
(GALL-A) Biliary Tract Cancers Biliary Tract Cancers: Intrahepatic Cholangiocarcinoma • Principles of Imaging (BIL-A) • Presentation, Workup, Primary Treatment (INTRA-1) • Principles of Radiation Therapy (BIL-B) • Adjuvant Treatment, Surveillance (INTRA-2) • Principles of Systemic ...
Final results from a phase IIstudy of infigratinib (BGJ398), an FGFR- selective tyrosine kinase inhibitor, in patients with previously treated advanced cholangiocarcinoma harboring anFGFR2 gene fusionor rearrangement.J Clin Oncol2021;39:265-265. MS-1 • 讨论部分已更新以反映程序的变化。 基于...
BIL-C3/3 更新Infigratinib的参考文献:JavleM,RoychowdhuryS,KelleyRK,etal.FinalresultsfromaphaseIIstudyofinfigratinib(BGJ398),anFGFR-selectivetyrosine kinaseinhibitor,inpatientswithpreviouslytreatedadvancedcholangiocarcinomaharboringanFGFR2genefusionorrearrangement.JClinOncol2021;39:265-265. MS-1 •更新了...
Intrahepatic Cholangiocarcinoma Extrahepatic Cholangiocarcinoma NCCN Framework for Resource Stratification of NCCN Guidelines (NCCN Framework™) – Hepatocellular Carcinoma and Gallbladder Cancer Basic Resources Core Resources Enhanced Resources NCCN Guidelines for Patients for Gallbladder and Bile Duct Cancers ...
Results Among 4519 patients who underwent resection for low-risk CCA, 55.5% (n = 2510) had intrahepatic, 15.0% (n = 680) had perihilar, and 29.4% (n = 1329) had distal cholangiocarcinoma. Adherence to NCCN guidelines increased from 27.7% in 2010 to 41.6% in 2017 (ptrend < 0.001) ...
原发性肝癌主要包括肝细胞癌(hepatocellular carcinoma,HCC)、肝内胆管癌(intrahepatic cholangiocarcinoma,ICC)和混合型肝细胞癌-胆管癌(combined hepatocellular-cholangiocarcinoma,cHCC-CCA),其中HCC占85%~90%[3]。2023年3月10日,美国国家综合癌症网络(National...
根据发生部位,胆管癌可分为肝内胆管癌(intrahepaticcholangiocarcinoma,ICC )及肝外胆管癌(extrahepaticcholangiocarcinoma,ECC),后者进一步分为肝门部胆管癌和远端胆管癌。目前根治性手术切除仍然是治疗胆管癌的主要方式,30%~40%的患者可行根治性手术切除,但术后局部复发及远处转移率较高,约为60%[3-4] 。近年来,国内...
(GALL-A)BiliaryTractCancers:IntrahepaticCholangiocarcinoma•Presentation,Workup,PrimaryTreatment(INTRA-1)•AdjuvantTreatment,Surveillance(INTRA-2)•PrinciplesofSurgery(INTRA-A)ractCancersExtrahepaticCholangiocarcinoma•Presentation,Workup,PrimaryTreatment(EXTRA-1)•AdjuvantTreatment,Surveillance(EXTRA-2)•...
Updates in Version 1.2022 of the NCCN Guidelines for Hepatobiliary Cancers from Version 5.2021 include:BIL-AReference 6 added: Sutton TL, Billingsley KG, Walker BS, et al. Detection of tumor multifocality in resectable intrahepatic cholangiocarcinoma: Defining the optimal pre-operative imaging ...